Susquehanna Advisors Group Inc. Purchases New Stake in Semler Scientific, Inc. (NASDAQ:SMLR)

Susquehanna Advisors Group Inc. acquired a new position in Semler Scientific, Inc. (NASDAQ:SMLR) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 498,675 shares of the company’s stock, valued at approximately $26,928,000. Semler Scientific accounts for 0.8% of Susquehanna Advisors Group Inc.’s portfolio, making the stock its 20th largest position. Susquehanna Advisors Group Inc. owned 0.05% of Semler Scientific as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently bought and sold shares of the business. Jones Financial Companies Lllp bought a new position in Semler Scientific in the 4th quarter worth about $34,000. Larson Financial Group LLC acquired a new stake in Semler Scientific in the 4th quarter valued at approximately $38,000. NewEdge Advisors LLC raised its stake in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock valued at $40,000 after acquiring an additional 557 shares in the last quarter. IFP Advisors Inc acquired a new position in Semler Scientific during the 4th quarter worth $54,000. Finally, Global Retirement Partners LLC grew its stake in shares of Semler Scientific by 62.5% in the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after purchasing an additional 500 shares in the last quarter. Institutional investors own 49.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital upped their price objective on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Semler Scientific Price Performance

NASDAQ SMLR opened at $29.83 on Tuesday. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The firm has a market capitalization of $286.28 million, a PE ratio of 6.08 and a beta of 1.29. The company’s 50 day simple moving average is $38.32 and its 200 day simple moving average is $45.99.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.